Skip to main content

Table 1 Baseline characteristics of 225 couples from the EARTH study in relation to female smoking status

From: Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction

 

Female Smoking Status

P-value a

Never smoker

Former smoker

Current smoker

Number of couples, n (%)

167 (74.2)

51 (22.7)

7 (3.1)

<0.001

Total ART cycles, n (%)

249 (70.3)

93 (26.3)

12 (3.4)

<0.001

Female Characteristics b

 Age, years

35 (32, 38)

34 (33, 37)

34 (29, 37)

0.89

 Body Mass Index, kg/m2

22.6 (20.4, 26.3)

22.7 (21.5, 24.7)

25.7 (23.8, 28.2)

0.11

 At least college education, n (%)

148 (88.6)

39 (76.5)

5 (71.4)

0.04

 Non-Hispanic Caucasian, n (%)

143 (85.6)

43 (84.3)

7 (100)

0.74

 Pack-years

NA

1.6 (0.5, 4.6)

2.4 (1.0, 4.2)

0.65

 Total smoking duration, years

NA

9 (5, 13)

14 (8, 16)

0.08

 Average cigarettes smoked

NA

4.0 (1.5, 10.0)

5.0 (1.5, 7.0)

0.89

 Age of smoking initiation, years

NA

17 (15, 18)

18 (18, 20)

0.04

 Total Smoking cessation, years

NA

8.0 (5.0, 12.0)

0.2 (0.2, 0.2)

<0.001

 Exposed to passive smoking, n (%)

30 (18.0)

14 (27.5)

2 (28.6)

0.23

Male Partner Characteristics

 Partner age, years

36 (33, 40)

35 (33, 40)

39 (35, 41)

0.40

 Partner body mass index, kg/m2

26.9 (24.2, 29.3)

26.9 (24.5, 29.3)

27.9 (25.1, 28.3)

0.97

 Partner former smoker, n (%)

38 (22.8)

16 (31.4)

1 (14.3)

0.44

 Partner current smoker, n (%)

8 (4.8)

4 (7.8)

4 (57.1)

<0.001

Baseline Reproductive Characteristics

 Previous IUI, n (%)

71 (42.5)

19 (37.3)

2 (28.6)

0.70

 Previous IVF, n (%)

40 (24.0)

8 (15.7)

1 (14.3)

0.51

 ICSI, n (%)

83 (49.7)

31 (60.8)

4 (57.1)

0.37

 Infertility diagnosis, n (%)

   

0.47

  Male factor

55 (32.9)

20 (39.2)

4 (57.1)

 

  Diminished ovarian reserve

9 (5.9)

3 (5.9)

1 (14.3)

 

  Endometriosis

10 (6.0)

3 (5.9)

0 (0.0)

 

  Ovulatory dysfunction

15 (9.0)

5 (9.8)

0 (0.0)

 

  Tubal causes

11 (6.6)

8 (15.7)

1 (14.3)

 

  Uterine causes

3 (1.8)

0 (0.0)

0 (0.0)

 

  Unexplained

64 (38.3)

12 (23.5)

1 (14.3)

 

 Initial treatment protocol, n (%)

   

0.69

  Antagonist

21 (12.6)

5 (9.8)

1 (14.3)

 

  Flare

17 (10.2)

8 (15.7)

0 (0.0)

 

  Luteal phase agonist

129 (77.3)

38 (75.5)

6 (85.7)

 

 Day 3 FSH levels, IU/L

6.6 (5.8, 8.0)

7.3 (6.0, 8.8)

8.1 (7.0, 8.3)

0.16

 E2 Trigger levels, pmol/L

2126 (1632, 2639)

1828 (1459, 2532)

1798 (1540, 1953)

0.17

 Day of embryo transfer, n (%)

   

0.01

  No transfer

11 (6.6)

4 (7.8)

2 (28.6)

 

  Day 2

4 (2.4)

5 (2.2)

0 (0.0)

 

  Day 3

79 (47.6)

29 (56.9)

1 (14.3)

 

  Day 5

72 (43.4)

13 (25.5)

4 (57.1)

 

 Number of embryos transferred, n (%)

   

<0.001

  No transfers

11 (6.6)

4 (7.8)

2 (28.6)

 

  1 embryo

42 (25.3)

2 (3.9)

2 (28.6)

 

  2 embryos

81 (48.8)

41 (80.4)

3 (42.7)

 

  3 or more embryos

32 (19.3)

4 (7.8)

0 (0.0)

 
  1. aFrom Chi-square or Fisher test for discrete variables and Kruskal-Wallis for continuous variables
  2. bContinuous variables are presented as median (25th percentile, 75th percentile) while categorical variables are presented as number of women (percent)
  3. Abbreviations: ART Assisted reproductive technology, BMI Body mass index, E2 estradiol, FSH follicle stimulating hormone, IVF In-vitro fertilization, ICSI Intracytoplasmic sperm injection, IUI intrauterine sperm insemination